Abstract
Nontraditional models of care, including pharmacist-led management, have emerged to improve access to evidence-based cystitis treatment. Drawing from studies in Canada, New Zealand, the United Kingdom, and the United States, evidence demonstrates that pharmacists can safely and effectively manage cystitis using established protocols without compromising antimicrobial stewardship. These models expedite patient access to care while maintaining quality and safety. With more than 15 years of international experience supporting pharmacist-led cystitis management, policymakers and professional organizations have robust data to guide implementation and inform ongoing debates on optimizing care delivery.
Keywords
Get full access to this article
View all access options for this article.
